100 related articles for article (PubMed ID: 1949739)
21. [The immunological reactivity of patients with acute odontogenic inflammatory diseases].
Robustova TG; Biberman IaM; Starodubtsev VS; Shaĭdullin MS; Kostishin ID
Voen Med Zh; 1990 Sep; (9):52-4. PubMed ID: 2264305
[No Abstract] [Full Text] [Related]
22. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
Volosevich LI; Lukach EV; Krivokhatskaia LD
Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
[TBL] [Abstract][Full Text] [Related]
23. [Immune reactivity in anesthesiologists].
Mozhaev GA; Zakorzhevskiĭ IB
Anesteziol Reanimatol; 1982; (6):49-52. PubMed ID: 6984296
[No Abstract] [Full Text] [Related]
24. [A system of individual immunotherapy with leakadin in the combined therapy of acoustic neurinomas].
Starchenko AA; Khil'ko VA; Komarets SA; Khlunovskiĭ AN; Prilukova TI; Kraskovskaia SV; Danilov AV
Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):15-8. PubMed ID: 9092246
[TBL] [Abstract][Full Text] [Related]
25. [Cytostatic treatment of polycythemia vera with a methylbenzylhydrazine derivative].
Martin H; Schubert JC
Dtsch Med Wochenschr; 1966 Jan; 91(2):55-7. PubMed ID: 5900941
[No Abstract] [Full Text] [Related]
26. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine].
Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA
Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769
[TBL] [Abstract][Full Text] [Related]
27. [T- and B-cellular immunity system in thyrotoxicosis patients treated with thyrostatic preparations].
Kabatsiĭ NP
Vrach Delo; 1984 Feb; (2):80-2. PubMed ID: 6202062
[No Abstract] [Full Text] [Related]
28. [Disordered immunologic reactivity in patients with chronic calculous cholecystitis].
Koval'chuk LA; Venger IK; Piatnochka VI
Klin Khir (1962); 1989; (9):6-7. PubMed ID: 2593528
[TBL] [Abstract][Full Text] [Related]
29. [Trial to influence polycythemia with erythrocyte-antibodies. I. Preliminary clinical results].
Hrubisko M; Fãbryovã L; Lipsic T
Vnitr Lek; 1971 Sep; 17(9):879-87. PubMed ID: 5129135
[No Abstract] [Full Text] [Related]
30. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients].
Urasiński I; Mysik M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127
[No Abstract] [Full Text] [Related]
31. [Evaluation of various indicators of cellular immunity in persons exposed to work environment in the Masovian Refinery and Petrochemical Plants in Plock].
Tchórzewski H; Zeman K; Sułowska Z; Baj Z; Rzetelski B; Pacześniak J; Majewska E; Kocur E; Pokoca L; Soszyńska W
Med Pr; 1988; 39(2):100-7. PubMed ID: 3264874
[TBL] [Abstract][Full Text] [Related]
32. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S
Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495
[TBL] [Abstract][Full Text] [Related]
33. [On the treatment of hemoblastoses with N-diethyleneimidophosphonyl-N-phenylurea (C 73)].
Gerhartz H; Staeuber PG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):54-61. PubMed ID: 4157882
[No Abstract] [Full Text] [Related]
34. [Dynamics of the immunological reactivity indices in children withh chronic bronchopulmonary processes treated with staphylococcal autovaccine].
Mikheeva GA; Abirov MA
Vopr Okhr Materin Det; 1976 Nov; 21(11):48-52. PubMed ID: 1007127
[No Abstract] [Full Text] [Related]
35. [Cytostatic therapy of chronic myelosis and polycythemia vera with myelobromol (dibrommannitol)].
Helbig W; Schwenke H; Müldner J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(2):182-96. PubMed ID: 4189864
[No Abstract] [Full Text] [Related]
36. Polycythemia vera in a patient with the human immunodeficiency virus: a case report.
Sassaki MG; Souza CA; Siciliano RF; Leite AG; Padilha SL
Braz J Infect Dis; 2000 Aug; 4(4):204-7. PubMed ID: 11184768
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the therapeutic value of mmyeloglobol in polycythemia vera, based on 5-years of obervations].
Szentkláray J
Orv Hetil; 1969 Mar; 110(12):651-3. PubMed ID: 5767732
[No Abstract] [Full Text] [Related]
38. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
Böhnel J; Stacher A
Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
[No Abstract] [Full Text] [Related]
39. [Immunological reactivity and the nonspecific protection factors in the severe form of tetanus].
Treshchinskiĭ AI; Mozhaev GA; Svirgunenko IuP; Spitsyn ON; Kraevaia SB
Anesteziol Reanimatol; 1980 Aug; (4):48-51. PubMed ID: 6968165
[No Abstract] [Full Text] [Related]
40. [T-lymphocyte content in the blood in nephrotuberculosis under antibactertial and immunostimulation therapy].
Mukanbaev K; Vladimirskiĭ MA
Probl Tuberk; 1980 Aug; (8):40-2. PubMed ID: 6967603
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
